3553 results for «2204»

Filter By

3553 results

TAVI access

21 Nov 2021 – From PCR London Valves 2021

Watch this series of videos from PCR London Valves 2021 for clinical outcomes after single access transfemoral transcatheter aortic valve implantation, to consider transcaval TAVI as a reliable alternative, to appreciate a fully percutaneous subclavian approach for TAVI, and much more!

TAVI access

Comparing outcomes and haemodynamics after TAVI

21 Nov 2021 – From PCR London Valves 2021

Learn more about the results of various bioprostheses, transcatheter heart valves, and other TAVI devices through the various comparisons presented in this PCR London Valves 2021 session.

Comparing outcomes and haemodynamics after TAVI

Coronary artery access and revascularisation after TAVI

21 Nov 2021 – From PCR London Valves 2021

Find out more about coronary access post-TAVI in this PCR London Valves 2021 session, witness a coronary intervention after self-expanding TAVI or SAVR in low-risk patients, and review two-year outcomes following TAVI or SAVR in patients stratified by need for revascularisation, among others!

Coronary artery access and revascularisation after TAVI

Pacemaker implantation after TAVI

21 Nov 2021 – From PCR London Valves 2021

Through this series of videos from PCR London Valves 2021, learn about the early outcomes of using the novel frame alignment technique during TAVI to improve pacemaker rates, see how cusp overlap projection reduces the burden of permanent pacemaker implantation after TAVR, appreciate the clinical utility of...

Pacemaker implantation after TAVI

TAVI in bicuspid aortic valves

21 Nov 2021 – From PCR London Valves 2021

Thanks to this series of videos from PCR London Valves 2021, analyze the results of self-expandable versus balloon-expandable transcatheter valves in bicuspid aortic anatomy, study the outcomes after TAVI in bicuspid aortic valve, and much more!

TAVI in bicuspid aortic valves

Tailoring mitral and tricuspid dedicated clip therapies by unlocking their full potential

22 Nov 2021 – From PCR London Valves 2021

Plunge into the universe of mitral and tricuspid in this PCR London Valves 2021 session, and learn how to optimize patient selection and tailor our procedural strategy, understand how to optimize patient outcomes with dedicated devices, and experience how to maximize the use of the G4...

Tailoring mitral and tricuspid dedicated clip therapies by unlocking their full potential

TAVI procedure planning and optimising patient outcomes

21 Nov 2021 – From PCR London Valves 2021

Watch this series of videos from PCR London Valves 2021 to evaluate whether TAVICT scans can replace invasive coronary angiography pre-TAVI, to appreciate how pre-operative computed tomography evaluation of aortic burden can predict acute kidney injury post-TAVR, and to appraise mortality in TAVI patients converted to...

TAVI procedure planning and optimising patient outcomes

The Navitor with FlexNav TAVI system: when smooth implantability allows to optimise TAVI outcomes

21 Nov 2021 – From PCR London Valves 2021

In this session from the PCR London Valves 2021 Congress, find out more about the new Navitor valve and FlexNav delivery system, discover how to achieve favourable patient outcomes, and learn how choosing a device can impact patient lifetime management.

The Navitor with FlexNav TAVI system: when smooth implantability allows to optimise TAVI outcomes

Outcomes after novel transcatheter and surgical tricuspid valve interventions

21 Nov 2021 – From PCR London Valves 2021

Find out more about TRI-SCORE, a new risk score to predict in-hospital mortality after isolated tricuspid valve surgery, 30-day outcomes for transcatheter tricuspid repair from the TriBAND study, both the CLASP TR early feasibility and TRISCEND studies six-month results, and more in this PCR London Valves...

Outcomes after novel transcatheter and surgical tricuspid valve interventions

Outcomes following transcatheter and percutaneous mitral valve repair

21 Nov 2021 – From PCR London Valves 2021

CLASP study, predictability of post-delivery residual mitral regurgitation, MiCLASP PMCF study, off-pump transapical neochord implantation, pronostic impact of nutritional status, and patients with low, intermediate and high frailty are the focus of this session from PCR LV 2021 devoted to percutaneous and transcatheter mitral valve repair.

Outcomes following transcatheter and percutaneous mitral valve repair

Transcatheter mitral valve replacement: patient selection and hemodynamic stability

22 Nov 2021 – From PCR London Valves

Watch this session broadcast at PCR London Valves 2021 to find out more about TMVR as a novel treatment option for patients with mitral disease, to learn how to identify the right candidate for TMVR, and to understand how to best medically manage patients peri-procedurally.

Transcatheter mitral valve replacement: patient selection and hemodynamic stability

Transcatheter mitral, aortic and pulmonary valve implantation

21 Nov 2021 – From PCR London Valves 2021

Watch this series of videos from PCR London Valves 2021 to learn about acute heart failure hospitalizations following TAVI in the U.S., share a peripheral hospital's experiences with structural valve service modernization, enjoy percutaneous transseptal mitral valve implantation in Brazil, and more!

Transcatheter mitral, aortic and pulmonary valve implantation

Obtaining commissural alignment in TAVI

23 Nov 2021 – From PCR London Valves 2021

Watch this session from PCR London Valves 2021 about the importance of commissural alignment in TAVI to know how to achieve commissural alignment with different TAVI systems, and to discover a step-by-step demonstration of patient-specific commissural alignment with the ACURATE neo2 THV system.

Obtaining commissural

Lifetime management of patients with severe aortic stenosis

22 Nov 2021 – From PCR London Valves

Don't miss this PCR London Valves 2021 session if you wish to discuss the importance of lifetime management in patients with severe aortic stenosis, to learn about the latest CoreLab adjudicated outcomes from the Early neo2 registry, and to understand how valve design, implant technique, embolic...

Lifetime management of patients with severe aortic stenosis

Miscellaneous - Paravalvular leak closure, PFO closure and LAA occlusion

21 Nov 2021 – From PCR London Valves 2021

Want to know more about the impact of baseline PFO anatomy on residual right to left shunt after transcatheter closure, transcatheter closure of paravalvular leak, or even percutaneous mitral paravalvular leak closure using CT planning? This PCR London Valves 2021 session is for you!

Miscellaneous - Paravalvular leak closure, PFO closure and LAA occlusion

Seeing is believing: predictable and durable treatment of mitral regurgitation across etiologies with the PASCAL platform

23 Nov 2021 – From PCR London Valves

Explore the clinical impact of the Edwards portfolio of transcatheter devices for mitral regurgitation treatment in this PCR London Valves 2021 session that you shouldn't miss if you want to attend case-based discussions that will analyze key PASCAL features to treat mitral regurgitation and to participate...

Seeing is believing: predictable and durable treatment of mitral regurgitation across etiologies with the PASCAL platform

PCR London Valves 2021 Hotlines / Late-Breaking Trials: bRIGHT, EXPAND, CHOICE-MI

21 Nov 2021 – From PCR London Valves

Real-world outcomes for tricuspid edge-to-edge repair, predictors of heart failure hospitalisation and its impact on clinical outcomes, one-year outcomes after TMVI... View part of the Late-Breaking Trials presented during PCR London Valves 2021.

PCR London Valves 2021 Hotlines / Late-Breaking Trials: bRIGHT, EXPAND, CHOICE-MI

From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options

21 Nov 2021 – From PCR London Valves 2021

Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned. Bernard Prendergast, Philipp Lurz, Fabien Praz and Maurizio Taramasso discuss the challenges and needs regarding mitral and tricuspid valve disease treatment. They also consider what is needed to...

From TAVI to mitral and

From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options - Part 1 - Best long-term outcomes start with the first procedure

21 Nov 2021 – From PCR London Valves

In this session from PCR London Valve 2021 dedicated to TAVI, mitral, and tricuspid, let's examine the issues related to the lifetime patient journey faced by many patients, starting with an analysis of severe aortic stenosis: how to identify the most important factors when considering the...

From TAVI to mitral and tricuspid - Part 1 - Best long-term outcomes start with the first procedure

From TAVI to mitral and tricupid - Applying evidence to expand patients' treatment options - Part 2 - Securing long-term patient options

22 Nov 2021 – From PCR London Valves

Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned, as you can notice in this session broadcast at PCR London Valves 2021 Congress, focusing on this topic area. Watch it now if you wish to understand how key...

From TAVI to mitral and tricupid - Part 2 - Securing long-term patient options
Didn’t find what you were looking for?